These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 11493028)

  • 1. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
    Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
    Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
    Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M; Hoffer BJ; Olson L
    J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
    Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
    Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
    Shingo T; Date I; Yoshida H; Ohmoto T
    J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.